Our top pick for
Building a portfolio
Forte Biosciences, Inc is a biotechnology business based in the US. Forte Biosciences shares (FBRX) are listed on the NASDAQ and all prices are listed in US Dollars. Forte Biosciences employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
|52-week range||$13.35 - $53.99|
|50-day moving average||$30.29|
|200-day moving average||$35.52|
|Wall St. target price||$88.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-35.69|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Gross profit TTM||$0|
|Return on assets TTM||-25.81%|
|Return on equity TTM||-143.64%|
|Market capitalisation||$494.8 million|
TTM: trailing 12 months
There are currently 609,549 Forte Biosciences shares held short by investors – that's known as Forte Biosciences's "short interest". This figure is 6.1% down from 648,916 last month.
There are a few different ways that this level of interest in shorting Forte Biosciences shares can be evaluated.
Forte Biosciences's "short interest ratio" (SIR) is the quantity of Forte Biosciences shares currently shorted divided by the average quantity of Forte Biosciences shares traded daily (recently around 324228.19148936). Forte Biosciences's SIR currently stands at 1.88. In other words for every 100,000 Forte Biosciences shares traded daily on the market, roughly 1880 shares are currently held short.
However Forte Biosciences's short interest can also be evaluated against the total number of Forte Biosciences shares, or, against the total number of tradable Forte Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Forte Biosciences's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Forte Biosciences shares in existence, roughly 50 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Forte Biosciences shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Forte Biosciences.
Find out more about how you can short Forte Biosciences stock.
We're not expecting Forte Biosciences to pay a dividend over the next 12 months.
Forte Biosciences's shares were split on a 1:15 basis on 15 June 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Forte Biosciences shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Forte Biosciences shares which in turn could have impacted Forte Biosciences's share price.
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California. .
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.